D-0571-2016 Class III Terminated

Recalled by Morton Grove Pharmaceuticals, Inc. — Morton Grove, IL

FDA drug recall D-0571-2016 was initiated by Morton Grove Pharmaceuticals, Inc. on Dec 15, 2015 and is designated Class III. Reason for recall: Super-Potent Drug: Out of Specification Assay test results were reported for stability samples. The recall status is terminated (terminated Sep 13, 2016). Affected quantity: 39,187 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 27, 2016
Initiation Date
Dec 15, 2015
Termination Date
Sep 13, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
39,187 bottles

Product description

Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60

Reason for recall

Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: UP1103, Exp 04/2016; UQ1001, Exp 04/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0571-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0571-2016. Report a data issue: hello@regdatalab.com.